PRAXIS PRECISION MEDICINES I
1 day chart
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalances. The Company is applying genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small molecule platform, which utilizes understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally precision therapies; and Solidus, is an antisense oligonucleotide (ASO) platform, which targets precision medicine discovery and development engine anchored on a proprietary, computational methodology. Its product candidates include PRAX-944, PRAX-562, PRAX-628 and PRAX-222.
Buy US stocks in Australia starting with PRAX. Open an account and start investing today!
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake Wall St
- Deposit directly into your Stake wallet and you're ready to invest in PRAX
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.